Orchard Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding from Q4 2018 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Orchard Therapeutics plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2018 to Q3 2023.
  • Orchard Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending November 9, 2023 was 228M shares, a 79.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 228M +101M +79.7% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 227M +101M +79.7% Jul 31, 2023 10-Q 2023-08-10
Q1 2023 184M +58.1M +46.2% Mar 10, 2023 10-K 2023-03-14
Q3 2022 127M +1.19M +0.95% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 126M +1.09M +0.87% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 126M +2.07M +1.67% Mar 15, 2022 10-K 2022-03-30
Q3 2021 125M +27.7M +28.4% Oct 31, 2021 10-Q 2021-11-04
Q2 2021 125M +27.8M +28.5% Jul 31, 2021 10-Q 2021-08-04
Q1 2021 124M +26.5M +27.3% May 4, 2021 10-Q 2021-05-13
Q3 2020 97.7M Oct 30, 2020 10-Q 2020-11-03
Q2 2020 97.6M Jul 31, 2020 10-Q 2020-08-06
Q1 2020 97.3M May 4, 2020 10-Q 2020-05-07
Q4 2019 97.1M +11.2M +13% Feb 14, 2020 10-K 2020-02-27
Q4 2018 85.9M Dec 31, 2018 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.